Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Boyle, A. J
Right arrow Articles by Itescu, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyle, A. J
Right arrow Articles by Itescu, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Additive effects of endothelial progenitor cells combined with ACE inhibition and β-blockade on left ventricular function following acute myocardial infarction

Andrew J Boyle

University of Melbourne, Department of Medicine, St Vincent's Hospital, Princes St, Fitzroy 3065, Victoria, Australia, aboyle@medstv. unimelb.edu.au, Columbia University, College of Physicians and Surgeons, 14-402 630 West, 168th St New York, NY

Michael Schuster

Columbia University, College of Physicians and Surgeons, 14-402 630 West, 168th St New York, NY

Piotr Witkowski

Columbia University, College of Physicians and Surgeons, 14-402 630 West, 168th St New York, NY, Medical University of Gdansk, Gdansk, Poland

Guosheng Xiang

Columbia University, College of Physicians and Surgeons, 14-402 630 West, 168th St New York, NY

Tetsunori Seki

Columbia University, College of Physicians and Surgeons, 14-402 630 West, 168th St New York, NY

Kerrie Way

University of Melbourne, Department of Medicine, St Vincent's Hospital, Princes St, Fitzroy 3065, Victoria, Australia, Columbia University, College of Physicians and Surgeons, 14-402 630 West, 168th St New York, NY

Silviu Itescu

University of Melbourne, Department of Medicine, St Vincent's Hospital, Princes St, Fitzroy 3065, Victoria, Australia, Columbia University, College of Physicians and Surgeons, 14-402 630 West, 168th St New York, NY

Animal studies have demonstrated the efficacy of endothelial progenitor cells (EPCs) in preventing left ventricular (LV) remodelling following myocardial infarction (MI). Preliminary human studies are underway, yet no studies have demonstrated efficacy in combination with standard medical therapy, i.e. angiotensin-converting enzyme (ACE) inhibitors and β-blockers. Nude rats underwent left anterior descending coronary artery ligation to induce MI. Animals were randomised to receive no treatment (MI, n=5), quinapril 200 mg/L + metoprolol 2 g/L (ACE/BB, n=5), two million EPCs intravenously (EPC, n=5)or both (ACE/BB + EPC [n=5]), then sacrificed after two weeks treatment. ACE/BB resulted in a 75% reduction in fibrosis in the region remote from the MI (p<0.05), but EPC therapy had little effect here. Conversely, EPC therapy induced neovascularisation at the peri-infarct rim, thereby preventing peri-infarct apoptosis by 81% (p<0.05). Acting via different but complementary mechanisms, the combination of ACE/BB + EPCs resulted in a greater overall improvement in LV function on echocardiography than either therapy alone. Clinical trials using stem cell therapy in conjunction with standard medical treatment are warranted.

Key Words: stem cell • myocardial infarction • remodelling • heart failure

Journal of Renin-Angiotensin-Aldosterone System, Vol. 6, No. 1, 33-37 (2005)
DOI: 10.3317/jraas.2005.004


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
E. L. Olivares, R. H. Costa-e-Sousa, J. P.S. Werneck-de-Castro, V. Pinho-Ribeiro, M. G. Silva, K. C. Ribeiro, E. C. Mattos, R. C.S. Goldenberg, A. C. C. de Carvalho, and M. O. Masuda
Cellular cardiomyoplasty in large myocardial infarction: Can the beneficial effect be enhanced by ACE-inhibitor therapy?
Eur J Heart Fail, June 1, 2007; 9(6-7): 558 - 567.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Post and J. Waltenberger
ACE inhibitors and statins for bone marrow failure following myocardial infarction?
Cardiovasc Res, April 1, 2006; 70(1): 1 - 2.
[Full Text] [PDF]



Advertisement